Daicel Corporation

4202.T
Specialty Chemicals
2026/11/05 12:54 Updated
Market Cap: $2.3B (¥369.2B)
Stock Price: $9.12 (¥1,445)
Exchange Rate: 1 USD = ¥158.48

Notice of Revision to Some Numerical Targets of the Mid-Term Strategy “Accelerate 2030”

Revisions to some numerical targets of the mid-term strategy Accelerate 2030. Reflecting demand trends for Materials and High-Performance Polymers and a reassessment of capital expenditures, the company has lowered indicators such as net sales, operating income, and ROE/ROIC/ROA for fiscal years 2028 and 2030.

Importance:
Page Updated: November 5, 2026
IR Disclosure Date: November 5, 2026

Key Figures

  • Revised company total net sales 6,950 hundred million yen (fiscal 2028)
  • Revised company total operating income 720 hundred million yen (fiscal 2028)
  • ROE 13%, ROIC 7.5%, ROA 5% (fiscal 2028)

AI要約

Overview of Mid-Term Strategy Revisions

Daicel Corporation has revised some numerical targets of its mid-term strategy Accelerate 2030. The revisions reflect a review of assumptions on sales volume and unit prices in the Materials business, a reassessment of capital expenditures, and expected demand expansion for optical connectors for AI data centers. Fiscal 2028 is positioned as a key year, and the company will thoroughly confirm progress and review measures to ensure achievement of the plan.

Summary of Revisions and Impacts

Revised figures for sales and operating income by segment were disclosed. For fiscal 2028, High-Performance Polymers net sales are revised to 2,740 hundred million yen and operating income to 340 hundred million yen; Materials net sales are revised to 2,160 hundred million yen and operating income to 160 hundred million yen; company total net sales are revised to 6,950 hundred million yen and operating income to 720 hundred million yen. EBITDA, ROE, ROIC, and ROA have also been updated with respective revisions/improvements.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daicel Corporation

Company overview · Stock price · Financial data · All IR

View company page →